Structural Activity Relationship Analysis of New Diphenyl PFI-3 Analogues Targeting for the Treatment of Glioblastoma

<b data-eusoft-scrollable-element="1">Background/Objectives</b>: Human glioblastoma (GBM) is the most aggressive brain cancer in adults and a highly treatment-refractory malignancy. The overall prognosis for the GBM is extremely poor, with a median survival of 12–14 months after initial diagnosis. M...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dong-Jin Hwang, Chuanhe Yang, Yinan Wang, Hannah Kelso, Satyanarayana Pochampally, Lawrence M. Pfeffer, Duane D. Miller
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-04-01
coleção:	Pharmaceuticals
Assuntos:	bromodomain glioblastoma (GBM) therapeutic enhancing drug (TED) anti-GBM activity structure–activity relationship (SAR) PFI-3 analog
Acesso em linha:	https://www.mdpi.com/1424-8247/18/5/608
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!